• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!

Oxfendazole Development Group — Oxfendazole Toxicity Tests

Visit Grantee Site
  • Portfolio Area: Human Health and Wellbeing
  • Focus Area: Scientific Research
  • Organization Name: Oxfendazole Development Group
  • Amount: $1,600,000

  • Award Date: June 2022

Table of Contents

    Open Philanthropy recommended a grant of $1,600,000 over three years to the Oxfendazole Development Group to support their work conducting animal toxicity tests for oxfendazole, a veterinary deworming medicine, as part of a larger project focused on getting it approved to treat whipworm and other human parasitic diseases.

    This falls within our focus area of scientific research, specifically within our interest in advancing human health and wellbeing.

    Related Items

    • Human Health and Wellbeing

      Harvard University — CRISPR-Based Diagnostics for Febrile Diseases

      Open Philanthropy recommended a grant of $600,123 over two years to Harvard University to support research led by James Collins on developing CRISPR-based diagnostics for febrile (fever-inducing) diseases. Many deadly...

      Read more
    • Human Health and Wellbeing

      London School of Hygiene and Tropical Medicine — Research on Chronic Viral Infections 

      Open Philanthropy recommended a grant of £1,961,252 (approximately $2,670,441 at the time of conversion) over five years to the London School of Hygiene and Tropical Medicine to support...

      Read more
    • Human Health and Wellbeing

      Stanford University — Immunization Research

      Open Philanthropy recommended a grant of $350,000 to Stanford University to support research led by Professor Michael Fischbach on a novel immunization method. Professor Fischbach recently discovered that exposing mice...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    • Stay Updated
    Mailing Address
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    © Open Philanthropy 2022 This work is licensed under a Creative Commons Attribution-Noncommercial-Share-alike 4.0 International License. If you'd like to translate this content into another language, please get in touch!